世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034634

女性用避妊具の世界市場規模調査・予測:避妊薬別、デバイス別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Female Contraceptive Market Size study & Forecast, by Contraceptive Drugs (Oral Contraceptives, Topical Contraceptives, Contraceptive Injections, Spermicides), By Devices (Female Condoms, Diaphragms and Caps, Vaginal Rings, Contraceptive Sponges, Sub-dermal Contraceptive Implants, Intra-Uterine Contraceptive Copper Devices (IUCDs), Other Devices) and Regional Analysis, 2022-2029

発刊日 2023/03/06

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000034634

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

女性用避妊具の世界市場は、予測期間の2022年から2029年には8.5%以上の健全な成長率で成長すると予測されています。

女性用避妊具市場には、女性の妊娠を予防するために設計された様々な製品が含まれています。最も一般的な女性用避妊製品の種類には、ホルモン性避妊具(避妊ピル、パッチ、注射など)、バリア方式(コンドーム、ダイアフラムなど)、子宮内器具(IUD)、避妊手術(卵管結紮、子宮摘出など)があります。市場の需要は、主に性感染症(STD)の蔓延、望まない妊娠の増加、避妊具に対する国民の意識の高まりといった要因によってもたらされます。

また、無防備な性行為や望まない妊娠によって引き起こされる様々な感染症の蔓延と出現が、市場成長の主要な促進要因として作用しています。国連人口基金によると、計画外妊娠は世界の全妊娠の50%以上を占め、毎年1億2100万件が発生しています。意図しない妊娠の60%以上が中絶に至り、全中絶の45%が安全でないと推定され、全妊婦死亡の5〜13%を引き起こしています。同様に、世界保健機関の推計によると、2020年には、クラミジア(1億2900万人)、淋病(8200万人)、梅毒(710万人)、トリコモナス(1億5600万人)の4つの性感染症のいずれかへの新規感染が約3億7400万人検出されています。これらの病気の可能性と計画外の妊娠が避妊具の必要性を高めているため、これらの要因が世界市場における女性用避妊製品の需要をエスカレートさせると予想されます。さらに、避妊法の使用に向けた政府の取り組みや制度の増加、避妊具を使用しない女性の数の増加は、今後数年間の市場成長にとって有利な機会をもたらしています。しかし、避妊薬や避妊具の副作用が、2022-2029年の予測期間における市場成長を制限しています。

女性用避妊具の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、高度なヘルスケアインフラが存在し、避妊薬や避妊具の採用率が高いことから、収益面で市場を独占しています。一方、アジア太平洋地域は、予測期間中に最も高い成長率で成長すると予想されています。政府の取り組み、望まない妊娠の増加、採用率の上昇などの要因が、予測期間中の市場成長を急拡大させます。

  • 主要企業
    ➣ Bayer AG
    ➣ Pfizer Inc.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Agile Therapeutics
    ➣ Organon
    ➣ Afaxys Pharma, LLC.
    ➣ Amgen Inc.
    ➣ ANSELL LTD.
    ➣ COOPERSURGICAL, INC.
    ➣ Cupid Limited
  • 調査対象年
    ➣ 実績データ - 2019 - 2020 - 2021年
    ➣ 基準年 - 2021年
    ➣ 予測期間 - 2022 - 2029年

本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

  • 市場セグメント・サブセグメント
    ➣ 避妊薬別
      ◇ 経口避妊薬
      ◇ 局所避妊薬
      ◇ 避妊用注射剤
      ◇ 殺精子剤
    ➣ デバイス別
      ◇ 女性用コンドーム
      ◇ ダイヤフラムとキャップ
      ◇ 膣リング
      ◇ 避妊用スポンジ
      ◇ 皮下避妊用インプラント
      ◇ 子宮内避妊用銅製器具(IUCD)
      ◇ その他のデバイス
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ ドラッグストア・調剤薬局
      ◇ オンラインプロバイダー
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ その他のラテンアメリカ
      ◇ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Female Contraceptive Market, by Region, 2019-2029 (USD Million)
1.2.2. Female Contraceptive Market, by Contraceptive Drugs , 2019-2029 (USD Million)
1.2.3. Female Contraceptive Market, by Devices, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Female Contraceptive Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Female Contraceptive Market Dynamics
3.1. Female Contraceptive Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of Sexually Transmitted Diseases (STDs)
3.1.1.2. Rising number of unwanted pregnancies
3.1.1.3. Rising public awareness towards contraceptive products
3.1.2. Market Challenges
3.1.2.1. Adverse consequences of contraceptive medicines and devices
3.1.3. Market Opportunities
3.1.3.1. Increasing government initiatives and schemes towards using contraceptive methods
3.1.3.2. Rising number of women with unmet contraceptive products

Chapter 4. Global Female Contraceptive Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Female Contraceptive Market, by Contraceptive Drugs
6.1. Market Snapshot
6.2. Global Female Contraceptive Market by Contraceptive Drugs , Performance - Potential Analysis
6.3. Global Female Contraceptive Market Estimates & Forecasts by Contraceptive Drugs 2019-2029 (USD Million)
6.4. Female Contraceptive Market, Sub Segment Analysis
6.4.1. Oral Contraceptives
6.4.2. Topical Contraceptives
6.4.3. Contraceptive Injections
6.4.4. Spermicides

Chapter 7. Global Female Contraceptive Market, by Devices
7.1. Market Snapshot
7.2. Global Female Contraceptive Market by Devices, Performance - Potential Analysis
7.3. Global Female Contraceptive Market Estimates & Forecasts by Devices 2019-2029 (USD Million)
7.4. Female Contraceptive Market, Sub Segment Analysis
7.4.1. Female Condoms
7.4.2. Diaphragms and Caps
7.4.3. Vaginal Rings
7.4.4. Contraceptive Sponges
7.4.5. Sub-dermal Contraceptive Implants
7.4.6. Intra-Uterine Contraceptive Copper Devices(IUCDs)
7.4.7. Other Devices

Chapter 8. Global Female Contraceptive Market, Regional Analysis
8.1. Female Contraceptive Market, Regional Market Snapshot
8.2. North America Female Contraceptive Market
8.2.1. U.S. Female Contraceptive Market
8.2.1.1. Contraceptive Drugs breakdown estimates & forecasts, 2019-2029
8.2.1.2. Devices breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Female Contraceptive Market
8.3. Europe Female Contraceptive Market Snapshot
8.3.1. U.K. Female Contraceptive Market
8.3.2. Germany Female Contraceptive Market
8.3.3. France Female Contraceptive Market
8.3.4. Spain Female Contraceptive Market
8.3.5. Italy Female Contraceptive Market
8.3.6. Rest of Europe Female Contraceptive Market
8.4. Asia-Pacific Female Contraceptive Market Snapshot
8.4.1. China Female Contraceptive Market
8.4.2. India Female Contraceptive Market
8.4.3. Japan Female Contraceptive Market
8.4.4. Australia Female Contraceptive Market
8.4.5. South Korea Female Contraceptive Market
8.4.6. Rest of Asia Pacific Female Contraceptive Market
8.5. Latin America Female Contraceptive Market Snapshot
8.5.1. Brazil Female Contraceptive Market
8.5.2. Mexico Female Contraceptive Market
8.5.3. Rest of Latin America Female Contraceptive Market
8.6. Rest of The World Female Contraceptive Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bayer AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Pfizer Inc.
9.2.3. Teva Pharmaceutical Industries Ltd.
9.2.4. Agile Therapeutics
9.2.5. Organon
9.2.6. Afaxys Pharma, LLC.
9.2.7. Amgen Inc.
9.2.8. ANSELL LTD.
9.2.9. COOPERSURGICAL, INC.
9.2.10. Cupid Limited

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Female Contraceptive Market, report scope
TABLE 2. Global Female Contraceptive Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Female Contraceptive Market estimates & forecasts by Contraceptive Drugs 2019-2029 (USD Million)
TABLE 4. Global Female Contraceptive Market estimates & forecasts by Devices 2019-2029 (USD Million)
TABLE 5. Global Female Contraceptive Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 6. Global Female Contraceptive Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Female Contraceptive Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Female Contraceptive Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Female Contraceptive Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Female Contraceptive Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Female Contraceptive Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Female Contraceptive Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Female Contraceptive Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Female Contraceptive Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. U.S. Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 17. U.S. Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. Canada Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 19. Canada Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. UK Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 22. UK Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. Germany Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 25. Germany Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. France Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 28. France Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. Italy Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 31. Italy Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Spain Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 34. Spain Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. RoE Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 37. RoE Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. China Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 40. China Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. India Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 43. India Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. Japan Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 46. Japan Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. South Korea Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 49. South Korea Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. Australia Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 52. Australia Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. RoAPAC Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 55. RoAPAC Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. Brazil Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 58. Brazil Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Mexico Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 61. Mexico Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. RoLA Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 64. RoLA Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. Row Female Contraceptive Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 67. Row Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row Female Contraceptive Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Female Contraceptive Market
TABLE 70. List of primary sources, used in the study of global Female Contraceptive Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Female Contraceptive Market, research methodology
FIG 2. Global Female Contraceptive Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Female Contraceptive Market, key trends 2021
FIG 5. Global Female Contraceptive Market, growth prospects 2022-2029
FIG 6. Global Female Contraceptive Market, porters 5 force model
FIG 7. Global Female Contraceptive Market, pest analysis
FIG 8. Global Female Contraceptive Market, value chain analysis
FIG 9. Global Female Contraceptive Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Female Contraceptive Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Female Contraceptive Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Female Contraceptive Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Female Contraceptive Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Female Contraceptive Market, regional snapshot 2019 & 2029
FIG 15. North America Female Contraceptive Market 2019 & 2029 (USD Million)
FIG 16. Europe Female Contraceptive Market 2019 & 2029 (USD Million)
FIG 17. Asia Pacific Female Contraceptive Market 2019 & 2029 (USD Million)
FIG 18. Latin America Female Contraceptive Market 2019 & 2029 (USD Million)
FIG 19. Global Female Contraceptive Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000034634

TOP